ABSTRACT The Health Promotion Board (HPB) has updated the clinical practice guidelines on Treating Tobacco Use and Dependence to provide health professionals in Singapore with evidence-based interventions for smoking cessation. This article reproduces the introduction and executive summary of key guideline recommendations (with recommendations from the guidelines) from the HPB-MOH Clinical Practice Guidelines on Treating Tobacco Use and Dependence, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Health Promotion Board website: http://www.hpb.gov.sg/cpg-smoking-cessation. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
INTRODUCTION

Objectives of guidelines
The aim of these guidelines is to assist all health professionals to identify and assess the tobacco use status of every patient and to deliver evidence-based effective tobacco use and dependence treatments.
Target users
The guidelines are intended for all health professionals, including doctors, dentists, psychologists, pharmacists, dieticians, social workers, occupational therapists, physiotherapists and nurses to assist them in their tobacco use cessation initiatives.
Emerging trends of tobacco use
Global trends
Tobacco use continues to be the leading global cause of preventable death and is a major public health threat to human health. The World Health Organization estimates that about 5 million people die prematurely each year from tobacco-related diseases.
If the current trend continues, by the year 2030 tobacco use will kill more than 8 million people worldwide each year; with 80% of these premature deaths occurring in low-and middle-income countries. By the end of the century, tobacco will kill a billion people or more unless urgent action is taken.
Tobacco smokers are not only putting themselves at risk but also 1.8 billion non-smokers worldwide. In 2004, it was estimated that 40% of children, 33% of male and 35% of female non-smokers worldwide were exposed to environmental tobacco smoke (ETS).
Smoking prevalence in Singapore
The prevalence rate of daily cigarette smoking among Singaporeans has increased from 12.6% in 2004 to 14.3% in 2010. In 2010, the smoking prevalence was about 6 times higher among males (24.7%) compared to females (4.2%).
When compared across the ethnic groups, the proportion of smokers was highest among the Malays (26.5%), followed by Among students, 6% of secondary 1 to 4 students smoked at least 1 day in the past 30 days. These students first experimented with cigarettes when they were 13 years old.
Social influencers play a part in an adolescent's uptake of smoking, with statistics clearly indicating that adolescents were more likely to pick up smoking if they had a parent, sibling or friend who smoked.
Harmful effects of tobacco
Tobacco use is a major risk factor for many diseases and is also the number one preventable cause of death in the world.
On average, a smoker dies 14 years prematurely due to tobaccorelated diseases compared to a non-smoker.
The harmful effects of tobacco use are well documented in numerous studies. Tobacco use harms almost every organ in the human body as shown in Figure 1 .
Harmful effects of second-hand tobacco smoke
Second-hand tobacco smoke, also known as environmental tobacco smoke (ETS), is a combination of 'sidestream' smoke (the smoke that is given out by the burning of tobacco product)
and 'mainstream' smoke (the smoke exhaled by the smoker).
It is also the tobacco smoke that fills the air in restaurants, workplaces, bars, cars, homes and other enclosed spaces when tobacco users burn tobacco products such as cigarettes, cigars, bidis and shisha/waterpipes.
There are more than 4000 chemicals in tobacco smoke, of which at least 250 are known to be harmful and more than 60 are known to cause cancer. There is no safe level of exposure to second-hand tobacco smoke.
In 2004, approximately 603,000 deaths were attributed to second-hand tobacco smoke worldwide. Globally, exposure to second-hand tobacco smoke has been estimated to have caused 379,000 deaths from ischaemic heart disease, 165,000 from lower respiratory infections, 36,900 from asthma, and 21,400 from lung cancer. Forty-seven percent of deaths from second-hand tobacco smoke occurred in women, 28% in children, and 26% in men. It was also estimated that living with a tobacco user increases the non-smokers' risk of developing lung cancer by 20% to 30%.
Third-hand tobacco smoke
Third-hand smoke first appeared in medical literature in 2009
and it refers to residual tobacco smoke that remains on indoor surfaces after the cigarette has been extinguished. This residue can react with common indoor air to produce dangerous cancer-causing carcinogens. It includes ultrafine chemical particles and volatile organic compounds, some of which are known to be toxic. Absorption of these particles could either occur through respiration, ingestion or through the skin.
Third-hand smoke is of concern particularly among young children living in tobacco-using households.
Although there appears to be an increasing interest and research on this, current evidence on its effects on health is still not well documented.
Harmful effects of other forms of tobacco products
All forms of tobacco are harmful and addictive. There is no safe tobacco product. Other forms of tobacco products include smokeless tobacco (also called chewing tobacco, snuff), pipes, cigars, rolled tobacco, shisha/waterpipes, bidis and others.
Cigar users are at risk of cancers of the lung, oral cavity, larynx and oesophagus. Heavy cigar smokers who inhale deeply are also at increased risk of coronary heart disease and chronic obstructive pulmonary disease. Similarly, smokers who smoke pipes are at higher risks of coronary heart disease and cerebrovascular disease when compared to nonsmokers. Studies also showed that shisha/waterpipes contain similar harmful chemicals as cigarettes and are as addictive as cigarettes.
The use of other forms of tobacco products has become more prevalent especially among the adolescents globally. In Singapore, among secondary 1 to 4 students who reported smoking at least 1 day in the past 30 days, 28.8% indicated using other forms of tobacco products such as shisha/ waterpipes, chewing tobacco, bidis and others. This will be an area of concern if the prevalence of using other forms of tobacco product increases.
Benefits of quitting
Quitting tobacco use has major and immediate health benefits for both men and women of all ages. It is also well established through numerous scientific studies that quitting tobacco use improves health and quality of life almost immediately.
The benefits can start after 20 minutes of quitting tobacco use (see Figure 2 ). 
E xECUTIvE SUMMARy AND kE y GUIDELINE RECOMMENDATIONS Executive Summary
Treating tobacco use and dependence is an important public health goal that will improve the quality of care and the health of all Singaporeans. The primary goal of the clinical practice guidelines is to reduce the prevalence of tobacco use and dependence through cessation treatments.
There is strong evidence to show that tobacco use causes many chronic diseases such as ischaemic heart disease, stroke, 
Key Guideline Recommendations
Details of recommendations can be found in the main text at the pages indicated. 
Non-pharmacological interventions
